Abstract:Spinocerebellar ataxia 27B is caused by a (GAA)•(TTC) repeat expansion in intron 1 of FGF14 and is a common cause of adult‐onset ataxia, accounting for 9–61% of previously undiagnosed cases in different ethnically diverse cohorts. The core phenotype consists of a late‐onset slowly progressive pan‐cerebellar syndrome with frequent oculomotor signs. Episodic symptoms, visual disturbances and downbeat nystagmus are commonly observed in patients with SCA27B. 4‐Aminopyridine is a promising symptomatic treatment. Hereditary ataxias, especially when presenting sporadically in adulthood, present a particular diagnostic challenge owing to their great clinical and genetic heterogeneity. Currently, up to 75% of such patients remain without a genetic diagnosis. In an era of emerging disease‐modifying gene‐stratified therapies, the identification of causative alleles has become increasingly important. Over the past few years, the implementation of advanced bioinformatics tools and long‐read sequencing has allowed the identification of a number of novel repeat expansion disorders, such as the recently described spinocerebellar ataxia 27B (SCA27B) caused by a (GAA)•(TTC) repeat expansion in intron 1 of the fibroblast growth factor 14 (FGF14) gene. SCA27B is rapidly gaining recognition as one of the most common forms of adult‐onset hereditary ataxia, with several studies showing that it accounts for a substantial number (9–61%) of previously undiagnosed cases from different cohorts. First natural history studies and multiple reports have already outlined the progression and core phenotype of this novel disease, which consists of a late‐onset slowly progressive pan‐cerebellar syndrome that is frequently associated with cerebellar oculomotor signs, such as downbeat nystagmus, and episodic symptoms. Furthermore, preliminary studies in patients with SCA27B have shown promising symptomatic benefits of 4‐aminopyridine, an already marketed drug. This review describes the current knowledge of the genetic and molecular basis, epidemiology, clinical features and prospective treatment strategies in SCA27B.

Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: Expanding the phenotype

SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene

Novel mutation in exon11 of PRKCG (SCA14): A case report

A Familial Late-Onset Hereditary Ataxia Mimicking Pontocerebellar Hypoplasia Caused by A Novel Tsen54 Mutation

Comparison of two families with and without ataxia harboring novel variants in PRKCG

Spinocerebellar ataxia type 14 caused by a nonsense mutation in the PRKCG gene

The Clinical Features and Gene Mutation Analysis in a Pedigree of Spinocerebellar Ataxia Type 7

PKCγ mutations in spinocerebellar ataxia type 14 affect C1 domain accessibility and kinase activity leading to aberrant MAPK signaling

Early-onset phenotype in a patient with an intermediate allele and a large SCA1 expansion: a case report

Clinical and neurophysiological profile of four German families with spinocerebellar ataxia type 14

Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy

Novel heterozygous PRPH2 variant identified in a patient with spinocerebellar ataxia type 14 and macular dystrophy

Mutation Analysis of Protein Kinase Cγ Gene in Hereditary Spinocerebellar Ataxia Patients in Southern Chinese Han Nationality

Molecular Genetic Analysis of a New Form of Spinocerebellar Ataxia in a Chinese Han Family.

Spinocerebellar ataxia 27B: A novel, frequent and potentially treatable ataxia

A novel KCNC3 gene variant in the voltage-dependent Kv3.3 channel in an atypical form of SCA13 with dominant central vertigo

Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias

Clinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (SCA27B)

CACNA1G Causes Dominantly Inherited Myoclonus-Ataxia with Intellectual Disability: A Case Report

Autosomal dominant congenital non-progressive ataxia overlaps with the SCA15 locus

Pathogenic CWF19L1 variants as a novel cause of autosomal recessive cerebellar ataxia and atrophy